SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-001827
Filing Date
2021-02-25
Accepted
2021-02-25 16:18:01
Documents
122
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adap-20201231x10k.htm   iXBRL 10-K 3292706
2 EX-4.4 adap-20201231xex4d4.htm EX-4.4 128410
3 EX-21.1 adap-20201231xex21d1.htm EX-21.1 4754
4 EX-23.1 adap-20201231xex23d1.htm EX-23.1 3915
5 EX-31.1 adap-20201231xex31d1.htm EX-31.1 15312
6 EX-31.2 adap-20201231xex31d2.htm EX-31.2 15281
7 EX-32.1 adap-20201231xex32d1.htm EX-32.1 6648
8 EX-32.2 adap-20201231xex32d2.htm EX-32.2 6612
9 GRAPHIC adap-20201231x10k001.jpg GRAPHIC 31932
10 GRAPHIC adap-20201231x10k002.jpg GRAPHIC 29122
11 GRAPHIC adap-20201231x10k003.jpg GRAPHIC 28959
12 GRAPHIC adap-20201231x10k004.jpg GRAPHIC 16374
13 GRAPHIC adap-20201231x10k005.jpg GRAPHIC 25616
14 GRAPHIC adap-20201231x10k006.jpg GRAPHIC 30091
15 GRAPHIC adap-20201231x10k007.jpg GRAPHIC 48364
16 GRAPHIC adap-20201231x10k008.jpg GRAPHIC 50249
  Complete submission text file 0001558370-21-001827.txt   14073085

Data Files

Seq Description Document Type Size
17 EX-101.SCH adap-20201231.xsd EX-101.SCH 86944
18 EX-101.CAL adap-20201231_cal.xml EX-101.CAL 71854
19 EX-101.DEF adap-20201231_def.xml EX-101.DEF 307258
20 EX-101.LAB adap-20201231_lab.xml EX-101.LAB 701766
21 EX-101.PRE adap-20201231_pre.xml EX-101.PRE 550754
22 EXTRACTED XBRL INSTANCE DOCUMENT adap-20201231x10k_htm.xml XML 2842726
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37368 | Film No.: 21680594
SIC: 2836 Biological Products, (No Diagnostic Substances)